Iovance Biotherapeutics

IOVA stock is not Shariah-compliant

مدعوم بواسطة Zoya API

About Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics is a clinical-stage biotechnology company focused on developing and commercializing cancer immunotherapy products that harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies for its lead product candidate, lifileucel, targeting metastatic melanoma, cervical cancer, and head and neck squamous cell carcinoma. The company has collaborations and licensing agreements with various cancer centers, research institutions, and pharmaceutical companies.

الأسئلة المتداولة

Is Iovance Biotherapeutics (IOVA) stock halal to invest in?
As of , IOVA is not Shariah-compliant and therefore considered halal to invest in. This assessment is based on the data available in Iovance Biotherapeutics's most recent financial reports.
As of , IOVA is not Shariah-compliant and therefore not considered halal to invest in. This assessment is based on the data available in Iovance Biotherapeutics's most recent financial reports.
As of , IOVA is flagged as not Shariah-compliant in terms of Shariah compliance based on the company's latest financial reports. This means that while the company's operations do not definitively violate Islamic guidelines, there are certain aspects of Iovance Biotherapeutics's business that require careful consideration.
Does Iovance Biotherapeutics have any interest income?
Yes, Iovance Biotherapeutics does have interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Iovance Biotherapeutics reported revenue of 1189000 and interest income of 13043000. The interest income represents 91.65% of the combined total. It's worth noting that some companies may report additional interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
No, Iovance Biotherapeutics has not reported any interest income. According to the company's latest annual report for the fiscal year ending Dec 31, 2023, Iovance Biotherapeutics reported total revenue of 1189000, with no separate interest income disclosed. However, it's worth noting that some companies may report interest income as part of their revenue. For a detailed breakdown of all interest income and revenue segments, please refer to the full Shariah compliance report available in the Zoya app.
What guidelines are used to determine if Iovance Biotherapeutics stock is Shariah-compliant?
We use the guidelines set by the Accounting and Auditing Organization for Islamic Financial Institutions (AAOIFI) to assess Shariah compliance. AAOIFI is a leading international organization that establishes standards for Islamic finance. Their guidelines help determine if a company's business activities and financial structure align with Islamic principles. These standards are widely respected in the Islamic finance industry and provide a consistent framework for evaluating the Shariah compliance of stocks and other financial instruments. AAOIFI's Shariah board includes renowned scholars such as Sheikh Muhammad Taqi Usmani, Sheikh Mohamed Ali Elgari, Sheikh Abdullah AlManea, Sheikh Nizam Yaquby, and Dr. Aznan Hassan.
How often is Iovance Biotherapeutics stock reviewed for Shariah compliance?
The Shariah compliance status of Iovance Biotherapeutics stock is reviewed on a regular basis, with a minimum frequency of once per quarter. However, if there are any significant changes or major developments in the company's operations that may impact its compliance, an immediate review will be conducted to ensure ongoing adherence to Shariah principles.
How can I stay updated on Iovance Biotherapeutics's compliance status?
To stay informed, we recommend regularly checking Zoya for updates. You can also enable alerts within the Zoya app to receive notifications whenever there is a change in the Shariah compliance of IOVA, or any other stocks you are monitoring. This is particularly useful as Shariah compliance can fluctuate due to changes in a company's financial ratios or business activities.
Are dividends from Iovance Biotherapeutics stock considered halal?
Yes, dividends from IOVA are considered halal. However, you may need to purify a portion of the dividend if the company has any impermissible revenue. Shariah standards typically allow up to 5% of revenue from impermissible sources for a stock to remain compliant. To find the exact percentage of impermissible revenue for Iovance Biotherapeutics (IOVA), check the Zoya app. For more details on the purification process, read our comprehensive guide.
No, dividends from IOVA are not considered halal because the stock is currently not Shariah-compliant. When a stock is non-compliant, any dividends received from it are considered impermissible income and should be donated to charity as a form of purification. To learn more about the purification process and how to handle impermissible income, read our comprehensive guide.
Do I need to pay Zakat on my Iovance Biotherapeutics shares?
If you hold Iovance Biotherapeutics stock as an investment, through an Employee Stock Ownership Plan (ESOP), stock options, restricted stock units (RSUs), or any other form of stock ownership, and meet the Nisab threshold, you may be required to pay Zakat on it. The calculation of Zakat on investments can be complex and depends on various factors. To help make this easy, we've created a free Zakat calculator for stocks. For a more seamless experience, use the Zoya mobile app, where you can link your brokerage account to automatically import holdings.

How to buy Iovance Biotherapeutics (IOVA) stock on Zoya

  1. سجّل للحصول على حساب زويا مجاناً
    من السهل البدء. يمكنك التسجيل للحصول على حساب مباشرةً على موقعنا الإلكتروني أو عن طريق تنزيل تطبيق زويا لنظامي iOS أو أندرويد.
  2. اربط حساب وساطة
    تتعاون Zoya مع شركات وساطة رائدة مثل Alpaca وغيرها من أجل طريقة سلسة لشراء الأسهم وإدارتها من خلال Zoya.
  3. حدد المبلغ الذي تريد استثماره
    انتقل إلى شاشة البحث واكتب اسم السهم في شريط البحث. بعد ذلك، انقر على زر الشراء وأدخل المبلغ الذي ترغب في استثماره، سواء بالدولار أو عدد الأسهم. راجع سعر السهم في الوقت الحقيقي وكمية الأسهم المقدرة قبل تأكيد استثمارك.
  4. قم بإدارة محفظتك في مكان واحد
    يمكنك العثور على الأسهم التي اشتريتها حديثًا في محفظة Zoya الخاصة بك إلى جانب بقية ممتلكاتك. قم بتمكين التنبيهات للحصول على إشعارات بأي تغييرات في امتثال محفظتك للشريعة الإسلامية.

منشورات المنتدى

الأسهم ذات الصلة

See how Iovance Biotherapeutics compares with its peers: